Evaluating neurocognitive challenges in Latino children with leukemia.

An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.

NIH-funded research Baylor College of Medicine · NIH-10890728

This study is looking at how Latino children with acute lymphoblastic leukemia (ALL) might think and learn differently during and after their treatment compared to other kids, to help understand how these differences can affect their school and job opportunities later on.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10890728 on NIH RePORTER

What this research studies

This research investigates the neurocognitive disparities experienced by Latino children undergoing treatment for acute lymphoblastic leukemia (ALL). It aims to understand how these disparities affect educational and economic outcomes, focusing on both biological and non-biological factors. By analyzing a cohort of 400 children, the study will assess neurocognitive performance from diagnosis through seven years post-treatment, particularly comparing Latino children to their non-Latino counterparts. The research employs advanced neurocognitive assessments to identify the underlying causes of these disparities.

Who could benefit from this research

Good fit: Ideal candidates for this research are Latino children diagnosed with acute lymphoblastic leukemia who are currently undergoing or have completed treatment.

Not a fit: Patients who are not Latino or those diagnosed with other types of leukemia may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies and support systems for Latino children with leukemia, enhancing their long-term cognitive and educational outcomes.

How similar studies have performed: Previous research has indicated that addressing neurocognitive disparities in cancer survivors can lead to significant improvements in patient outcomes, suggesting that this approach has potential for success.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.